Project Grant K01DA065706
- Federal Project Grant Award Summary New York University has been awarded $201,250 by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) for a two-year project period from June 1, 2025, through May 31, 2027. This Project Grant supports basic neuroscience research investigating the synaptic organization of cholinergic interneurons in the nucleus accumbens, a brain region critical to motivated behaviors and implicated in substance use...
- Federal Project Grant Award Summary The University of Rochester received a $433,029 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded on March 15, 2026, with completion targeted for February 28, 2028. This award funds the development and pilot testing of a novel couples-based treatment intervention specifically designed for heterosexual couples where both partners have Dual Substance Use Disorders (DUD) involving...
- Federal Grant Award Summary The University of Michigan received a $170,744 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded on June 17, 2025. The research project, titled "The Glucocorticoid Receptor as a Top-Down Neuromolecular Mechanism of Inhibitory Control," investigates the neural mechanisms underlying impulsivity and behavioral disinhibition in individuals with substance use disorder (SUD). The...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $600,580 to the Regents of the University of Minnesota (Office of Sponsored Projects Administration) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and deliver a three-week summer training workshop on reproducible research in brain imaging genetics. The award, effective August 1, 2025, through July 31, 2028, addresses a critical gap in workforce training by equipping graduate-level...
- Federal Project Grant Award Summary New York University received a $390,687 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective August 1, 2025, with completion scheduled for April 30, 2030. This award supports neuroscience research investigating how multiregional brain interactions support value-based decision-making and belief updating relevant to addiction-related behaviors. The research focuses on characterizing...
- Federal Grant Award Summary American University received a $476,496 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 15, 2025, and concluding July 31, 2028. The grant funds fundamental neuroscience research investigating opioid signaling mechanisms in reward-guided decision-making within the rat prefrontal cortex, specifically the prelimbic area. The research employs a two-alternative forced choice...
- Federal Grant Award Summary New York University received a $169,489 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) on March 15, 2026, with completion targeted for February 29, 2028. This grant supports basic neuroscience research investigating the estrogenic regulation of neuromodulators and temporal discounting—the process by which animals assign value to delayed rewards. The research addresses a critical gap in...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Vermont & State Agricultural College a $726,620 Project Grant on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to establish the Healthy Brain and Child Development Study's Scientific Training in Addiction Research Techniques Program (HBCD-START). This comprehensive research education initiative, funded through the NIH's Helping to End Addiction Long-term...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $781,032 to The Research Foundation for the State University of New York on August 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support basic neuroscience research examining the interplay between limbic norepinephrine (NE) and dopamine (DA) circuits in sex differences in reward and aversion. The five-year project, extending through April 30, 2030, will map the anatomical and...
- Federal Grant Award Summary New York University School of Medicine received a $2.09 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded July 1, 2025, with a completion date of March 31, 2030. The award funds a population-based data linkage study characterizing complex opioid use disorder (OUD) care trajectories and outcomes following acute service utilization. The research applies novel analytical...
The University of Rochester received a $156,555 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective May 1, 2026, through April 30, 2031. This award supports a postdoctoral research training program focused on leveraging adolescent neuroplasticity mechanisms to enhance adult frontal dopaminergic circuit function in the context of neurodevelopmental disorders. The research investigates dopaminergic system dysfunction through advanced in vivo two-photon microscopy, neural circuit dissection, microglial physiology, and behavioral assays conducted at the University of Rochester's Del Monte Institute of Neuroscience. Under a structured mentorship model, the research team—led by co-mentors Drs. Kuan Wang, Zhigang He, Yi Zuo, and Julie Fudge—will deliver comprehensive training and research outputs examining mesocortical dopaminergic plasticity, neuroimmune interactions, and the potential therapeutic applications of reopening adult neural plasticity through dopamine receptor modulation. The project integrates developmental neuroscience expertise with transcriptomic and bioinformatic analyses to advance understanding of how adolescent-specific neural plasticity mechanisms might be leveraged to treat adult-onset psychiatric and neurodevelopmental conditions, positioning the trainee for independent research leadership in dopaminergic development and neuroimmune biology.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $156.6k | 4/21/26 |